Activity-based tyrosine phosphatomics using F2Pmp probes

We showed that the F2Pmp probe binds to PTP in a sequence-dependent manner. In addition, this study is the first successful example of comprehensive enrichment of classical PTP at the protein level. Furthermore, we found that F2Pmp probe can enrich PTPs in a PTP activity dependent manner. Using the F2Pmp probe, the fluctuation of PTPN1 and PTPN2 activities were revealed. This enrichment approach using the F2Pmp probe could be a generic tool for activity-based tyrosine phosphatomics.

[1]  Y. Ishihama,et al.  Peptide probes containing a non‐hydrolyzable phosphotyrosine‐mimetic residue for enrichment of protein tyrosine phosphatases , 2021, Proteomics.

[2]  V. Wong,et al.  Receptor tyrosine kinases and cancer: oncogenic mechanisms and therapeutic approaches , 2021, Oncogene.

[3]  A. Ciulli,et al.  Recent advances in synthetic and medicinal chemistry of phosphotyrosine and phosphonate-based phosphotyrosine analogues , 2020, RSC medicinal chemistry.

[4]  D. Pappin,et al.  Regulation of PTP1B activation through disruption of redox-complex formation , 2019, Nature Chemical Biology.

[5]  M. Mrksich,et al.  Profiling Protein Tyrosine Phosphatase Specificity with Self-Assembled Monolayers for Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry and Peptide Arrays , 2019, ACS Combinatorial Science.

[6]  Jan C. Refsgaard,et al.  Oncogenic Mutations Rewire Signaling Pathways by Switching Protein Recruitment to Phosphotyrosine Sites , 2019, Cell.

[7]  M. Noda,et al.  A head-to-toe dimerization has physiological relevance for ligand-induced inactivation of protein tyrosine receptor type Z , 2019, The Journal of Biological Chemistry.

[8]  Maja Köhn,et al.  The human DEPhOsphorylation Database DEPOD: 2019 update , 2019, Database J. Biol. Databases Curation.

[9]  W. Peti,et al.  A Quantitative Chemical Proteomic Strategy for Profiling Phosphoprotein Phosphatases from Yeast to Humans* , 2018, Molecular & Cellular Proteomics.

[10]  Cliff I. Stains,et al.  Interrogating Protein Phosphatases with Chemical Activity Probes. , 2018, Chemistry.

[11]  Heiner Koch,et al.  The target landscape of clinical kinase drugs , 2017, Science.

[12]  A. Stoker,et al.  Vanadium Compounds as PTP Inhibitors , 2017, Molecules.

[13]  Gerard Manning,et al.  Genomics and evolution of protein phosphatases , 2017, Science Signaling.

[14]  P. Beltrão,et al.  Identifications of Putative PKA Substrates with Quantitative Phosphoproteomics and Primary-Sequence-Based Scoring. , 2017, Journal of proteome research.

[15]  J. Heringa,et al.  Both Intrinsic Substrate Preference and Network Context Contribute to Substrate Selection of Classical Tyrosine Phosphatases* , 2017, The Journal of Biological Chemistry.

[16]  Jüergen Cox,et al.  The MaxQuant computational platform for mass spectrometry-based shotgun proteomics , 2016, Nature Protocols.

[17]  Marco Y. Hein,et al.  The Perseus computational platform for comprehensive analysis of (prote)omics data , 2016, Nature Methods.

[18]  A. Alonso,et al.  The extended human PTPome: a growing tyrosine phosphatase family , 2016, The FEBS journal.

[19]  P. Beltrão,et al.  Uncovering Phosphorylation-Based Specificities through Functional Interaction Networks* , 2015, Molecular & Cellular Proteomics.

[20]  M. Köhn,et al.  Azide-alkyne cycloaddition-mediated cyclization of phosphonopeptides and their evaluation as PTP1B binders and enrichment tools. , 2015, Bioorganic & medicinal chemistry.

[21]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[22]  Bin Zhang,et al.  PhosphoSitePlus, 2014: mutations, PTMs and recalibrations , 2014, Nucleic Acids Res..

[23]  Xianwen Chen,et al.  Diverse levels of sequence selectivity and catalytic efficiency of protein-tyrosine phosphatases. , 2014, Biochemistry.

[24]  J. Bernhagen,et al.  Development of accessible peptidic tool compounds to study the phosphatase PTP1B in intact cells. , 2014, ACS chemical biology.

[25]  Michele Tinti,et al.  The SH2 domain interaction landscape. , 2013, Cell reports.

[26]  S. Yao,et al.  Ugi reaction-assisted rapid assembly of affinity-based probes against potential protein tyrosine phosphatases. , 2012, Chemical communications.

[27]  A. Ostman,et al.  Regulation of protein tyrosine phosphatases by reversible oxidation. , 2011, Journal of biochemistry.

[28]  M. Moran,et al.  Global Proteomic Assessment of the Classical Protein-Tyrosine Phosphatome and “Redoxome” , 2011, Cell.

[29]  J. Flanagan,et al.  Proteoglycan-Specific Molecular Switch for RPTPσ Clustering and Neuronal Extension , 2011, Science.

[30]  Karunakaran A Kalesh,et al.  Peptide-based activity-based probes (ABPs) for target-specific profiling of protein tyrosine phosphatases (PTPs). , 2010, Chemical communications.

[31]  S. Hardy,et al.  Inside the human cancer tyrosine phosphatome , 2010, Nature Reviews Cancer.

[32]  J. Cox,et al.  Proteomics strategy for quantitative protein interaction profiling in cell extracts , 2009, Nature Methods.

[33]  M. Mann,et al.  The Phosphotyrosine Interactome of the Insulin Receptor Family and Its Substrates IRS-1 and IRS-2*S , 2009, Molecular & Cellular Proteomics.

[34]  Wen Hwa Lee,et al.  Large-Scale Structural Analysis of the Classical Human Protein Tyrosine Phosphatome , 2009, Cell.

[35]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[36]  M. Mann,et al.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.

[37]  Sanjai Kumar,et al.  Aryl vinyl sulfonates and sulfones as active site-directed and mechanism-based probes for protein tyrosine phosphatases. , 2008, Journal of the American Chemical Society.

[38]  H. Christofk,et al.  Pyruvate kinase M2 is a phosphotyrosine-binding protein , 2008, Nature.

[39]  Masaru Tomita,et al.  Phase transfer surfactant-aided trypsin digestion for membrane proteome analysis. , 2008, Journal of proteome research.

[40]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[41]  Bernhard Kuster,et al.  Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors , 2007, Nature Biotechnology.

[42]  M. Mann,et al.  Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips , 2007, Nature Protocols.

[43]  M. Mann,et al.  Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks , 2006, Cell.

[44]  Sanjai Kumar,et al.  Global analysis of protein tyrosine phosphatase activity with ultra-sensitive fluorescent probes. , 2006, Journal of proteome research.

[45]  C. Benes,et al.  The C2 domain of PKCdelta is a phosphotyrosine binding domain. , 2005, Cell.

[46]  N. Cheong,et al.  Tim50, a Component of the Mitochondrial Translocator, Regulates Mitochondrial Integrity and Cell Death* , 2004, Journal of Biological Chemistry.

[47]  A. Sandelin,et al.  Applied bioinformatics for the identification of regulatory elements , 2004, Nature Reviews Genetics.

[48]  Sanjai Kumar,et al.  Activity-based probes for protein tyrosine phosphatases. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Hsin‐Yi Wang,et al.  Design and synthesis of class-selective activity probes for protein tyrosine phosphatases. , 2002, Journal of proteome research.

[50]  Terrence R. Burke,et al.  Thermodynamic Study of Ligand Binding to Protein-tyrosine Phosphatase 1B and Its Substrate-trapping Mutants* , 2000, The Journal of Biological Chemistry.

[51]  J. Schlessinger.  Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.

[52]  S. Rhee,et al.  Reversible Inactivation of Protein-tyrosine Phosphatase 1B in A431 Cells Stimulated with Epidermal Growth Factor* , 1998, The Journal of Biological Chemistry.

[53]  L. Wu,et al.  Why is phosphonodifluoromethyl phenylalanine a more potent inhibitory moiety than phosphonomethyl phenylalanine toward protein-tyrosine phosphatases? , 1995, Biochemical and biophysical research communications.

[54]  S. Shoelson,et al.  Nonhydrolyzable phosphotyrosyl mimetics for the preparation of phosphatase-resistant SH2 domain inhibitors. , 1994, Biochemistry.

[55]  K. Emmerson,et al.  Epidermal growth factor (EGF) stimulation of ATP citrate lyase activity in isolated rat hepatocytes is age dependent. , 1992, Comparative biochemistry and physiology. B, Comparative biochemistry.

[56]  L. Harel,et al.  Early effect of growth factors (EGF + insulin) upon ATP turnover in 3T3 cells. Inhibition by cytochalasin B and D. , 1986, Experimental cell research.

[57]  L. Harel,et al.  Early effect of growth factors (EGF + insulin) upon ATP turnover in 3T3 cells. , 1983, Experimental cell research.